Treatment of diabetic ketoacidosis: Should mode of insulin administration dictate use of intensive care facilities?
Authors:
- Andrew R. HoffmanAHAndrew R. Hoffman
- 1 September 2004
- journal article
- editorial
- Published by Elsevier in The American Journal of Medicine
- Vol. 117 (5) , 357-358
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosisThe American Journal of Medicine, 2004
- Economic Impact of Diabetic Ketoacidosis in a Multiethnic Indigent PopulationDiabetes Care, 2003
- Diabetic Ketoacidosis Charges Relative to Medical Charges of Adult Patients With Type I DiabetesDiabetes Care, 1997
- Insulin Therapy for Diabetic Ketoacidosis: Bolus insulin injection versus continuous insulin infusionDiabetes Care, 1995
- Similar Responsiveness of Diabetic Ketoacidosis to Low-Dose Insulin by Intramuscular Injection and Albumin-Free InfusionAnnals of Internal Medicine, 1979
- Low-Dose Insulin in the Treatment of Diabetic KetoacidosisArchives of internal medicine (1960), 1977
- Diabetic Ketoacidosis: Low-Dose Insulin Therapy by Various RoutesNew England Journal of Medicine, 1977
- Low-Dose Intravenous Insulin Infusion Versus Subcutaneous Insulin Injection: A Controlled Comparative Study of Diabetic KetoacidosisPediatrics, 1977
- The Efficacy of Low-Dose Versus Conventional Therapy of Insulin for Treatment of Diabetic KetoacidosisAnnals of Internal Medicine, 1976